Clinical Trial Update: Ivabradine in Patients With an Unsatisfactory Percentage of Cardiac Resynchronization Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating ivabradine in heart failure patients with an unsatisfactory percentage of cardiac resynchronization therapy; current status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• IVABRADINE

Snippet

Sponsor: Medical University of Warsaw | Conditions: Heart Failure | Phase 4 | Status: UNKNOWN